Oxford Reportedly Suspends Dosing in Trial of AstraZeneca COVID Vaccine in Children, Teenagers

Apr 7, 2021 | EARNINGS

MOSCOW (Sputnik) – The University of Oxford announced that it has suspended administering doses of the vaccine against the novel coronavirus disease (COVID-19) that it developed with AstraZeneca, in a UK study on children and teenagers aged 6-17, The Wall Street Journal (WSJ) reported.

Read More

Pin It on Pinterest